| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dry Eye Syndromes | 86 | 2026 | 295 | 18.060 |
Why?
|
| Lacrimal Apparatus | 34 | 2026 | 125 | 12.830 |
Why?
|
| Sjogren's Syndrome | 29 | 2026 | 108 | 10.720 |
Why?
|
| Conjunctiva | 46 | 2026 | 196 | 7.430 |
Why?
|
| Epithelium, Corneal | 36 | 2025 | 174 | 6.980 |
Why?
|
| Cornea | 41 | 2026 | 565 | 6.100 |
Why?
|
| Aging | 22 | 2025 | 1242 | 5.750 |
Why?
|
| Goblet Cells | 28 | 2024 | 105 | 4.640 |
Why?
|
| Keratoconjunctivitis Sicca | 14 | 2026 | 50 | 4.480 |
Why?
|
| Tears | 35 | 2026 | 185 | 4.060 |
Why?
|
| Mice, Inbred C57BL | 78 | 2025 | 4714 | 3.970 |
Why?
|
| Interferon-gamma | 20 | 2022 | 550 | 3.400 |
Why?
|
| Disease Models, Animal | 54 | 2026 | 4666 | 3.200 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 9 | 2025 | 51 | 2.620 |
Why?
|
| Mice | 105 | 2026 | 18219 | 2.500 |
Why?
|
| Dacryocystitis | 5 | 2023 | 22 | 2.400 |
Why?
|
| Th1 Cells | 9 | 2024 | 159 | 2.390 |
Why?
|
| Burns, Chemical | 5 | 2017 | 31 | 2.340 |
Why?
|
| Animals | 119 | 2026 | 33846 | 2.140 |
Why?
|
| Mice, Knockout | 35 | 2025 | 3829 | 2.060 |
Why?
|
| Eye Burns | 5 | 2017 | 16 | 2.030 |
Why?
|
| Th17 Cells | 7 | 2024 | 97 | 1.900 |
Why?
|
| Eye | 11 | 2022 | 220 | 1.880 |
Why?
|
| Cathepsins | 4 | 2024 | 24 | 1.800 |
Why?
|
| CD4-Positive T-Lymphocytes | 15 | 2025 | 500 | 1.790 |
Why?
|
| Cytokines | 24 | 2025 | 1344 | 1.560 |
Why?
|
| Inflammation | 20 | 2023 | 1483 | 1.540 |
Why?
|
| Wound Healing | 5 | 2024 | 485 | 1.410 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2025 | 239 | 1.340 |
Why?
|
| Dendritic Cells | 13 | 2024 | 437 | 1.290 |
Why?
|
| Anti-Inflammatory Agents | 6 | 2016 | 298 | 1.220 |
Why?
|
| Butyrates | 2 | 2022 | 39 | 1.220 |
Why?
|
| Flow Cytometry | 10 | 2025 | 766 | 1.200 |
Why?
|
| Antigen-Presenting Cells | 3 | 2019 | 123 | 1.190 |
Why?
|
| Cyclosporine | 6 | 2026 | 131 | 1.170 |
Why?
|
| Dexamethasone | 5 | 2016 | 251 | 1.170 |
Why?
|
| Stress, Physiological | 11 | 2016 | 259 | 1.150 |
Why?
|
| Homeostasis | 4 | 2025 | 714 | 1.120 |
Why?
|
| Eye Diseases | 2 | 2021 | 108 | 1.110 |
Why?
|
| Gene Expression Regulation | 16 | 2025 | 2333 | 1.090 |
Why?
|
| Interleukin-13 | 4 | 2022 | 98 | 1.040 |
Why?
|
| Lipopolysaccharides | 4 | 2023 | 304 | 1.030 |
Why?
|
| Female | 86 | 2026 | 70312 | 1.020 |
Why?
|
| Lipid Metabolism | 5 | 2025 | 372 | 1.010 |
Why?
|
| Microbiota | 4 | 2025 | 438 | 0.990 |
Why?
|
| Adoptive Transfer | 13 | 2024 | 235 | 0.990 |
Why?
|
| Transcriptome | 4 | 2024 | 1113 | 0.990 |
Why?
|
| Phenylalanine | 2 | 2018 | 131 | 0.980 |
Why?
|
| Eye Proteins | 6 | 2026 | 225 | 0.960 |
Why?
|
| Real-Time Polymerase Chain Reaction | 13 | 2024 | 525 | 0.910 |
Why?
|
| Oxidative Stress | 4 | 2020 | 795 | 0.900 |
Why?
|
| Lipogenesis | 1 | 2025 | 62 | 0.900 |
Why?
|
| Xerophthalmia | 3 | 2014 | 8 | 0.880 |
Why?
|
| Desiccation | 15 | 2024 | 47 | 0.870 |
Why?
|
| RNA | 5 | 2016 | 515 | 0.870 |
Why?
|
| Ophthalmic Solutions | 9 | 2026 | 88 | 0.870 |
Why?
|
| Interleukin-17 | 7 | 2016 | 125 | 0.860 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2022 | 89 | 0.860 |
Why?
|
| Caloric Restriction | 1 | 2025 | 106 | 0.850 |
Why?
|
| Matrix Metalloproteinase 9 | 7 | 2015 | 134 | 0.840 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2022 | 831 | 0.840 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 762 | 0.820 |
Why?
|
| Keratoconjunctivitis | 3 | 2021 | 19 | 0.790 |
Why?
|
| Ophthalmic Nerve | 2 | 2026 | 8 | 0.790 |
Why?
|
| Lubricant Eye Drops | 3 | 2026 | 12 | 0.780 |
Why?
|
| Nerve Growth Factor | 1 | 2022 | 19 | 0.760 |
Why?
|
| Meibomian Glands | 7 | 2025 | 43 | 0.760 |
Why?
|
| Cells, Cultured | 21 | 2022 | 2894 | 0.750 |
Why?
|
| Th2 Cells | 6 | 2023 | 188 | 0.750 |
Why?
|
| Immunity, Innate | 8 | 2022 | 410 | 0.740 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 147 | 0.720 |
Why?
|
| Eye Injuries | 1 | 2022 | 49 | 0.710 |
Why?
|
| Corneal Injuries | 2 | 2024 | 34 | 0.710 |
Why?
|
| Homeodomain Proteins | 4 | 2018 | 562 | 0.700 |
Why?
|
| RNA, Messenger | 16 | 2018 | 2551 | 0.680 |
Why?
|
| Germ-Free Life | 2 | 2018 | 61 | 0.680 |
Why?
|
| Immune Tolerance | 5 | 2021 | 155 | 0.670 |
Why?
|
| Dysbiosis | 2 | 2019 | 143 | 0.670 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2011 | 13 | 0.670 |
Why?
|
| Inflammasomes | 4 | 2023 | 153 | 0.650 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 93 | 0.650 |
Why?
|
| Nerve Tissue | 1 | 2020 | 5 | 0.650 |
Why?
|
| Microscopy, Confocal | 14 | 2024 | 339 | 0.650 |
Why?
|
| Doxycycline | 4 | 2016 | 112 | 0.640 |
Why?
|
| Parity | 1 | 2020 | 77 | 0.640 |
Why?
|
| Axons | 2 | 2020 | 385 | 0.630 |
Why?
|
| Cell Proliferation | 6 | 2020 | 2464 | 0.620 |
Why?
|
| Alkalies | 5 | 2017 | 23 | 0.600 |
Why?
|
| Epithelial Cells | 14 | 2023 | 907 | 0.600 |
Why?
|
| Interferon Type I | 1 | 2020 | 120 | 0.590 |
Why?
|
| Conjunctivitis, Allergic | 5 | 2020 | 18 | 0.580 |
Why?
|
| Killer Cells, Natural | 2 | 2012 | 351 | 0.580 |
Why?
|
| Autoimmune Diseases | 2 | 2011 | 265 | 0.560 |
Why?
|
| T-Lymphocytes | 8 | 2017 | 1712 | 0.560 |
Why?
|
| Membrane Proteins | 9 | 2017 | 1591 | 0.560 |
Why?
|
| Sulfones | 1 | 2018 | 72 | 0.550 |
Why?
|
| Humans | 73 | 2026 | 130374 | 0.550 |
Why?
|
| Symbiosis | 1 | 2018 | 71 | 0.540 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2023 | 127 | 0.540 |
Why?
|
| Male | 47 | 2026 | 64435 | 0.540 |
Why?
|
| Cranial Nerve Diseases | 1 | 2018 | 28 | 0.530 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2016 | 141 | 0.530 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 13 | 2018 | 97 | 0.530 |
Why?
|
| Autoimmunity | 3 | 2017 | 178 | 0.490 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2016 | 15 | 0.480 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2014 | 464 | 0.480 |
Why?
|
| Mouth Mucosa | 1 | 2016 | 45 | 0.470 |
Why?
|
| Corneal Diseases | 2 | 2009 | 94 | 0.470 |
Why?
|
| Epithelium | 4 | 2023 | 336 | 0.470 |
Why?
|
| Methylprednisolone | 2 | 2006 | 94 | 0.470 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 15 | 0.460 |
Why?
|
| Interleukin-1 | 3 | 2025 | 129 | 0.450 |
Why?
|
| Thrombospondin 1 | 2 | 2023 | 23 | 0.450 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 13 | 0.440 |
Why?
|
| Protein Precursors | 9 | 2011 | 139 | 0.430 |
Why?
|
| Signal Transduction | 11 | 2022 | 4671 | 0.430 |
Why?
|
| Cell Count | 9 | 2020 | 214 | 0.430 |
Why?
|
| Biomarkers | 11 | 2026 | 3382 | 0.430 |
Why?
|
| Permeability | 6 | 2018 | 119 | 0.420 |
Why?
|
| Receptors, CCR6 | 1 | 2013 | 6 | 0.410 |
Why?
|
| Limbus Corneae | 5 | 2007 | 31 | 0.410 |
Why?
|
| Apoptosis | 8 | 2026 | 1828 | 0.410 |
Why?
|
| Receptors, CXCR3 | 1 | 2013 | 23 | 0.410 |
Why?
|
| Piperidines | 1 | 2015 | 229 | 0.400 |
Why?
|
| Glucocorticoids | 3 | 2016 | 345 | 0.400 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2019 | 196 | 0.390 |
Why?
|
| Phenotype | 9 | 2023 | 4471 | 0.390 |
Why?
|
| Immunohistochemistry | 12 | 2019 | 1595 | 0.380 |
Why?
|
| Blotting, Western | 8 | 2024 | 1016 | 0.380 |
Why?
|
| Corneal Topography | 3 | 2009 | 143 | 0.380 |
Why?
|
| Macrophages | 6 | 2024 | 660 | 0.380 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2012 | 1206 | 0.380 |
Why?
|
| Prodrugs | 1 | 2012 | 56 | 0.370 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 452 | 0.370 |
Why?
|
| Lymphoid Tissue | 2 | 2023 | 48 | 0.370 |
Why?
|
| Mucous Membrane | 3 | 2022 | 93 | 0.360 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2012 | 82 | 0.360 |
Why?
|
| Occludin | 4 | 2021 | 19 | 0.350 |
Why?
|
| Organic Chemicals | 4 | 2015 | 58 | 0.340 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 6 | 2011 | 19 | 0.330 |
Why?
|
| Mucin 5AC | 5 | 2020 | 23 | 0.330 |
Why?
|
| Aged | 21 | 2026 | 20865 | 0.330 |
Why?
|
| Cell Movement | 6 | 2016 | 870 | 0.320 |
Why?
|
| Administration, Topical | 5 | 2026 | 132 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2023 | 636 | 0.310 |
Why?
|
| Mice, Inbred NOD | 6 | 2026 | 302 | 0.310 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 4 | 2010 | 71 | 0.310 |
Why?
|
| Interleukin-12 | 3 | 2018 | 124 | 0.300 |
Why?
|
| Fluorescein | 5 | 2023 | 39 | 0.300 |
Why?
|
| B7-2 Antigen | 2 | 2019 | 16 | 0.300 |
Why?
|
| Cell Size | 2 | 2008 | 80 | 0.300 |
Why?
|
| Drug Delivery Systems | 3 | 2021 | 216 | 0.300 |
Why?
|
| ATP-Binding Cassette Transporters | 5 | 2008 | 192 | 0.290 |
Why?
|
| Immunosuppressive Agents | 3 | 2026 | 655 | 0.290 |
Why?
|
| Matrix Metalloproteinases | 3 | 2017 | 62 | 0.290 |
Why?
|
| Middle Aged | 25 | 2026 | 28371 | 0.290 |
Why?
|
| Adult | 25 | 2026 | 31099 | 0.280 |
Why?
|
| Keratomileusis, Laser In Situ | 2 | 2006 | 84 | 0.270 |
Why?
|
| Stem Cells | 8 | 2023 | 703 | 0.260 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2018 | 108 | 0.260 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2022 | 15 | 0.260 |
Why?
|
| Cell Differentiation | 8 | 2018 | 1920 | 0.260 |
Why?
|
| Chemokine CXCL11 | 2 | 2018 | 9 | 0.250 |
Why?
|
| Chemokine CXCL9 | 2 | 2018 | 14 | 0.250 |
Why?
|
| Lymphocyte Activation | 4 | 2019 | 633 | 0.240 |
Why?
|
| Biomedical Research | 2 | 2026 | 561 | 0.240 |
Why?
|
| Tertiary Lymphoid Structures | 1 | 2026 | 9 | 0.240 |
Why?
|
| Neoplasm Proteins | 5 | 2008 | 679 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2015 | 785 | 0.230 |
Why?
|
| Mice, Inbred BALB C | 8 | 2025 | 977 | 0.230 |
Why?
|
| B-Lymphocytes | 2 | 2023 | 511 | 0.230 |
Why?
|
| Delayed-Action Preparations | 2 | 2016 | 120 | 0.230 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2025 | 19 | 0.230 |
Why?
|
| Chemokine CXCL10 | 2 | 2016 | 52 | 0.230 |
Why?
|
| Interleukin-1beta | 4 | 2023 | 156 | 0.230 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 3029 | 0.230 |
Why?
|
| MicroRNAs | 2 | 2026 | 889 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 2 | 2026 | 411 | 0.220 |
Why?
|
| Myopia | 1 | 2006 | 121 | 0.220 |
Why?
|
| Tight Junction Proteins | 2 | 2021 | 14 | 0.220 |
Why?
|
| Chemokine CCL20 | 2 | 2016 | 17 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2018 | 413 | 0.220 |
Why?
|
| Chromatography, Liquid | 1 | 2025 | 233 | 0.210 |
Why?
|
| Re-Epithelialization | 1 | 2024 | 15 | 0.210 |
Why?
|
| Hyperesthesia | 1 | 2004 | 2 | 0.210 |
Why?
|
| Fluorophotometry | 4 | 2009 | 31 | 0.210 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2024 | 67 | 0.210 |
Why?
|
| Mass Spectrometry | 1 | 2025 | 358 | 0.200 |
Why?
|
| Air | 1 | 2004 | 21 | 0.200 |
Why?
|
| Debridement | 1 | 2024 | 86 | 0.200 |
Why?
|
| DNA, Bacterial | 1 | 2025 | 480 | 0.200 |
Why?
|
| Proteome | 1 | 2026 | 286 | 0.200 |
Why?
|
| Parabiosis | 1 | 2023 | 3 | 0.200 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 178 | 0.190 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 2 | 2016 | 16 | 0.190 |
Why?
|
| Receptor, trkC | 1 | 2022 | 13 | 0.190 |
Why?
|
| Up-Regulation | 1 | 2025 | 827 | 0.190 |
Why?
|
| Receptor, trkB | 1 | 2022 | 22 | 0.190 |
Why?
|
| Mitomycin | 1 | 2022 | 39 | 0.190 |
Why?
|
| Ligands | 2 | 2022 | 482 | 0.190 |
Why?
|
| Receptor, trkA | 1 | 2022 | 18 | 0.190 |
Why?
|
| Monocytes | 2 | 2022 | 336 | 0.190 |
Why?
|
| Interleukin-2 | 1 | 2023 | 236 | 0.190 |
Why?
|
| Cholinergic Antagonists | 3 | 2013 | 46 | 0.190 |
Why?
|
| Paracrine Communication | 1 | 2022 | 67 | 0.190 |
Why?
|
| Bone Marrow Cells | 4 | 2018 | 242 | 0.180 |
Why?
|
| Polysaccharides, Bacterial | 4 | 2014 | 65 | 0.180 |
Why?
|
| Keratoconus | 1 | 2003 | 51 | 0.180 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 2 | 2020 | 22 | 0.180 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2021 | 17 | 0.180 |
Why?
|
| Graft vs Host Disease | 2 | 2025 | 686 | 0.180 |
Why?
|
| Tretinoin | 2 | 2021 | 95 | 0.180 |
Why?
|
| Lipids | 1 | 2025 | 558 | 0.180 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 38 | 0.180 |
Why?
|
| Fatty Acids, Volatile | 1 | 2022 | 43 | 0.180 |
Why?
|
| Forkhead Transcription Factors | 4 | 2020 | 373 | 0.180 |
Why?
|
| Immune System | 2 | 2021 | 100 | 0.180 |
Why?
|
| Biological Transport | 2 | 2012 | 329 | 0.170 |
Why?
|
| Immune Privilege | 1 | 2021 | 1 | 0.170 |
Why?
|
| Sex Characteristics | 1 | 2023 | 323 | 0.170 |
Why?
|
| Bacteria | 1 | 2025 | 524 | 0.170 |
Why?
|
| Case-Control Studies | 4 | 2020 | 3355 | 0.170 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 352 | 0.170 |
Why?
|
| Glaucoma | 1 | 2022 | 84 | 0.170 |
Why?
|
| Retinoids | 1 | 2021 | 28 | 0.170 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2020 | 10 | 0.170 |
Why?
|
| Thiones | 1 | 2020 | 7 | 0.170 |
Why?
|
| Mucins | 3 | 2017 | 71 | 0.170 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2012 | 17 | 0.170 |
Why?
|
| Spleen | 1 | 2021 | 258 | 0.170 |
Why?
|
| Receptors, Interleukin-9 | 1 | 2020 | 2 | 0.160 |
Why?
|
| Interleukin-9 | 1 | 2020 | 7 | 0.160 |
Why?
|
| Interleukin-33 | 1 | 2020 | 21 | 0.160 |
Why?
|
| Calcineurin Inhibitors | 1 | 2020 | 25 | 0.160 |
Why?
|
| Thiophenes | 1 | 2020 | 68 | 0.160 |
Why?
|
| Pyrazines | 1 | 2020 | 79 | 0.160 |
Why?
|
| Chemokines | 3 | 2010 | 126 | 0.160 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 245 | 0.160 |
Why?
|
| Receptors, Chemokine | 2 | 2011 | 47 | 0.150 |
Why?
|
| Immunophenotyping | 2 | 2018 | 331 | 0.150 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 137 | 0.150 |
Why?
|
| Transforming Growth Factor beta2 | 2 | 2010 | 12 | 0.150 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 262 | 0.150 |
Why?
|
| Autoantibodies | 2 | 2012 | 440 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2026 | 1270 | 0.150 |
Why?
|
| Interleukin-27 | 1 | 2019 | 3 | 0.150 |
Why?
|
| Lysosomal-Associated Membrane Protein 3 | 1 | 2018 | 2 | 0.150 |
Why?
|
| Chemokine CXCL1 | 1 | 2018 | 15 | 0.150 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2018 | 15 | 0.150 |
Why?
|
| Beclin-1 | 1 | 2018 | 33 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2026 | 1806 | 0.140 |
Why?
|
| Nanostructures | 2 | 2016 | 66 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 330 | 0.140 |
Why?
|
| Humidity | 3 | 2015 | 26 | 0.140 |
Why?
|
| Transglutaminases | 3 | 2006 | 26 | 0.140 |
Why?
|
| Colony-Forming Units Assay | 3 | 2008 | 63 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 278 | 0.130 |
Why?
|
| Epidermal Growth Factor | 3 | 2012 | 115 | 0.130 |
Why?
|
| Caspase 8 | 1 | 2017 | 26 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 384 | 0.130 |
Why?
|
| Antibodies | 2 | 2017 | 320 | 0.130 |
Why?
|
| Flagellin | 2 | 2014 | 20 | 0.130 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2017 | 43 | 0.130 |
Why?
|
| Caspase 1 | 1 | 2017 | 49 | 0.130 |
Why?
|
| Dehydration | 2 | 2007 | 41 | 0.130 |
Why?
|
| Cellular Senescence | 1 | 2019 | 217 | 0.130 |
Why?
|
| Time Factors | 3 | 2013 | 6196 | 0.120 |
Why?
|
| Mice, Nude | 3 | 2012 | 698 | 0.120 |
Why?
|
| Cell Adhesion | 2 | 2015 | 306 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2025 | 1272 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 159 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 4 | 2010 | 234 | 0.120 |
Why?
|
| Tongue | 1 | 2016 | 28 | 0.120 |
Why?
|
| Unfolded Protein Response | 1 | 2016 | 67 | 0.120 |
Why?
|
| Blinking | 3 | 2015 | 27 | 0.120 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 63 | 0.120 |
Why?
|
| Integrin alpha4 | 1 | 2015 | 12 | 0.120 |
Why?
|
| Sensation | 2 | 2007 | 47 | 0.120 |
Why?
|
| Integrin alpha4beta1 | 1 | 2015 | 26 | 0.120 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2015 | 13 | 0.120 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 231 | 0.110 |
Why?
|
| Environment, Controlled | 1 | 2015 | 7 | 0.110 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 72 | 0.110 |
Why?
|
| NIH 3T3 Cells | 2 | 2005 | 91 | 0.110 |
Why?
|
| Disease Progression | 2 | 2026 | 2193 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 6783 | 0.110 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 6 | 0.110 |
Why?
|
| Conjunctival Diseases | 1 | 2015 | 31 | 0.110 |
Why?
|
| Autoantigens | 2 | 2012 | 100 | 0.110 |
Why?
|
| Antigens, Ly | 1 | 2014 | 31 | 0.110 |
Why?
|
| Cell Membrane Permeability | 2 | 2012 | 64 | 0.110 |
Why?
|
| Acute Disease | 1 | 2018 | 1147 | 0.110 |
Why?
|
| Cell Survival | 3 | 2012 | 831 | 0.110 |
Why?
|
| OX40 Ligand | 2 | 2011 | 9 | 0.110 |
Why?
|
| Bromodeoxyuridine | 4 | 2010 | 55 | 0.110 |
Why?
|
| Leukocytes | 1 | 2015 | 207 | 0.100 |
Why?
|
| Lymph Nodes | 2 | 2013 | 357 | 0.100 |
Why?
|
| Visual Acuity | 4 | 2009 | 526 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2018 | 792 | 0.100 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 228 | 0.100 |
Why?
|
| Neutrophils | 1 | 2016 | 361 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 2333 | 0.100 |
Why?
|
| Models, Animal | 3 | 2017 | 451 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2006 | 3113 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2013 | 123 | 0.100 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2004 | 82 | 0.100 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 96 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2010 | 143 | 0.090 |
Why?
|
| Feces | 1 | 2016 | 720 | 0.090 |
Why?
|
| Tissue Kallikreins | 1 | 2012 | 7 | 0.090 |
Why?
|
| Corneal Stroma | 1 | 2012 | 77 | 0.090 |
Why?
|
| Antigens, CD | 2 | 2012 | 411 | 0.090 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 2 | 2008 | 23 | 0.090 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2011 | 17 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2014 | 767 | 0.090 |
Why?
|
| Young Adult | 6 | 2026 | 9982 | 0.090 |
Why?
|
| Antigens, Differentiation | 1 | 2011 | 63 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 104 | 0.090 |
Why?
|
| Genes, Dominant | 1 | 2011 | 244 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2012 | 152 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2010 | 34 | 0.080 |
Why?
|
| Gene Expression | 2 | 2012 | 1486 | 0.080 |
Why?
|
| Bacterial Capsules | 3 | 2005 | 42 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2026 | 888 | 0.080 |
Why?
|
| Nasolacrimal Duct | 1 | 2010 | 24 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2009 | 18 | 0.080 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2009 | 23 | 0.080 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2009 | 10 | 0.070 |
Why?
|
| Intermediate Filament Proteins | 2 | 2006 | 21 | 0.070 |
Why?
|
| Interleukin-18 | 2 | 2023 | 75 | 0.070 |
Why?
|
| Biomedical Engineering | 1 | 2008 | 21 | 0.070 |
Why?
|
| Tetracycline | 1 | 2008 | 74 | 0.070 |
Why?
|
| Hyaluronan Receptors | 1 | 2008 | 64 | 0.070 |
Why?
|
| Cell Communication | 2 | 2020 | 189 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 1317 | 0.070 |
Why?
|
| Risk Factors | 2 | 2017 | 10941 | 0.070 |
Why?
|
| Surveys and Questionnaires | 4 | 2022 | 4031 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 2 | 2005 | 227 | 0.070 |
Why?
|
| Pregnancy | 1 | 2020 | 7392 | 0.070 |
Why?
|
| Cell Culture Techniques | 2 | 2008 | 275 | 0.070 |
Why?
|
| CD4-CD8 Ratio | 1 | 2007 | 10 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 67 | 0.070 |
Why?
|
| Blepharoplasty | 1 | 2007 | 24 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2018 | 58 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 157 | 0.060 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 525 | 0.060 |
Why?
|
| Eyelids | 1 | 2007 | 105 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2023 | 440 | 0.060 |
Why?
|
| Depression, Chemical | 1 | 2006 | 33 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2008 | 334 | 0.060 |
Why?
|
| Metaplasia | 1 | 2007 | 215 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 84 | 0.060 |
Why?
|
| GTP-Binding Proteins | 1 | 2006 | 157 | 0.060 |
Why?
|
| Chemokine CCL5 | 2 | 2021 | 53 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2011 | 120 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 124 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2015 | 6420 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 183 | 0.060 |
Why?
|
| Collagen Type IV | 1 | 2005 | 20 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 1210 | 0.060 |
Why?
|
| Caspases | 3 | 2011 | 152 | 0.060 |
Why?
|
| History, 18th Century | 1 | 2025 | 68 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2025 | 110 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2025 | 39 | 0.050 |
Why?
|
| Phagocytes | 1 | 2024 | 25 | 0.050 |
Why?
|
| Clone Cells | 1 | 2005 | 152 | 0.050 |
Why?
|
| Anti-Allergic Agents | 1 | 2004 | 28 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 302 | 0.050 |
Why?
|
| Androstadienes | 1 | 2004 | 50 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 2567 | 0.050 |
Why?
|
| Mechanoreceptors | 1 | 2004 | 12 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2006 | 179 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2025 | 1444 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2025 | 258 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2009 | 2423 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2025 | 378 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2025 | 363 | 0.050 |
Why?
|
| Nigericin | 1 | 2023 | 2 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2003 | 111 | 0.050 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2003 | 42 | 0.050 |
Why?
|
| Adaptive Immunity | 1 | 2023 | 102 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2022 | 45 | 0.050 |
Why?
|
| Immunity | 1 | 2023 | 179 | 0.040 |
Why?
|
| Astigmatism | 1 | 2003 | 112 | 0.040 |
Why?
|
| Proteomics | 1 | 2026 | 616 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 585 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2021 | 60 | 0.040 |
Why?
|
| Cell Division | 3 | 2010 | 718 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 393 | 0.040 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2021 | 6 | 0.040 |
Why?
|
| Vitamin A Deficiency | 1 | 2021 | 11 | 0.040 |
Why?
|
| Corneal Transplantation | 2 | 2012 | 44 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2021 | 77 | 0.040 |
Why?
|
| Cell Separation | 2 | 2011 | 220 | 0.040 |
Why?
|
| CD4 Antigens | 1 | 2020 | 52 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2004 | 17492 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2022 | 271 | 0.040 |
Why?
|
| Vitamin A | 1 | 2021 | 57 | 0.040 |
Why?
|
| Leukocyte Common Antigens | 1 | 2020 | 84 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 348 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 5152 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 3469 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2021 | 112 | 0.040 |
Why?
|
| Benzalkonium Compounds | 1 | 2019 | 4 | 0.040 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2019 | 11 | 0.040 |
Why?
|
| Blood | 1 | 2000 | 98 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 528 | 0.040 |
Why?
|
| Biomarkers, Tumor | 2 | 2005 | 1585 | 0.040 |
Why?
|
| Sirolimus | 1 | 2020 | 231 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 341 | 0.040 |
Why?
|
| Chromans | 1 | 2018 | 8 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 2013 | 166 | 0.040 |
Why?
|
| Benzoates | 1 | 2018 | 25 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 852 | 0.040 |
Why?
|
| Incidence | 1 | 2006 | 3313 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2088 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 1456 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 105 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2005 | 486 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2017 | 114 | 0.030 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2017 | 11 | 0.030 |
Why?
|
| Adolescent | 4 | 2017 | 20712 | 0.030 |
Why?
|
| Ultraviolet Rays | 2 | 2006 | 191 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 291 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2015 | 65 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1244 | 0.030 |
Why?
|
| Integrin beta1 | 2 | 2005 | 53 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2015 | 235 | 0.030 |
Why?
|
| Connexin 43 | 2 | 2004 | 34 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 526 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 322 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2017 | 289 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2013 | 29 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2005 | 198 | 0.030 |
Why?
|
| Cell Line | 2 | 2010 | 2557 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 308 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 83 | 0.030 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2013 | 23 | 0.030 |
Why?
|
| DNA Damage | 1 | 2017 | 510 | 0.030 |
Why?
|
| Lissamine Green Dyes | 1 | 2013 | 8 | 0.020 |
Why?
|
| Eye Protective Devices | 1 | 2013 | 11 | 0.020 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2013 | 6 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2013 | 29 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2013 | 36 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2013 | 47 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 51 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 63 | 0.020 |
Why?
|
| Complement C3b | 1 | 2012 | 7 | 0.020 |
Why?
|
| Kallikreins | 1 | 2012 | 26 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2005 | 450 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 93 | 0.020 |
Why?
|
| DNA-Binding Proteins | 3 | 2005 | 1948 | 0.020 |
Why?
|
| Quality of Life | 1 | 2022 | 2073 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 255 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2014 | 316 | 0.020 |
Why?
|
| Complement Activation | 1 | 2012 | 50 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2012 | 122 | 0.020 |
Why?
|
| Quinazolines | 1 | 2013 | 177 | 0.020 |
Why?
|
| Ambrosia | 1 | 2011 | 14 | 0.020 |
Why?
|
| Receptors, Interferon | 1 | 2011 | 19 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 73 | 0.020 |
Why?
|
| fas Receptor | 1 | 2011 | 40 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 79 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 2011 | 26 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2011 | 38 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 934 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2011 | 134 | 0.020 |
Why?
|
| Trans-Activators | 2 | 2005 | 701 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2011 | 226 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 173 | 0.020 |
Why?
|
| Receptors, OX40 | 1 | 2010 | 9 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2010 | 11 | 0.020 |
Why?
|
| Poly I-C | 1 | 2010 | 20 | 0.020 |
Why?
|
| Osmosis | 1 | 2010 | 17 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 106 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2010 | 66 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2010 | 35 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2010 | 82 | 0.020 |
Why?
|
| Pollen | 1 | 2010 | 38 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 230 | 0.020 |
Why?
|
| Plant Proteins | 1 | 2010 | 86 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2010 | 156 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 2008 | 17 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 793 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2826 | 0.020 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2008 | 2 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2008 | 19 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2008 | 119 | 0.020 |
Why?
|
| Eyelid Diseases | 1 | 2008 | 58 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2008 | 41 | 0.020 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2007 | 5 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 242 | 0.020 |
Why?
|
| Emulsions | 1 | 2008 | 69 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2008 | 227 | 0.020 |
Why?
|
| Interleukins | 1 | 2008 | 121 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 409 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 277 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2011 | 687 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 410 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2007 | 364 | 0.020 |
Why?
|
| Allergens | 1 | 2010 | 344 | 0.020 |
Why?
|
| Blepharoptosis | 1 | 2007 | 67 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2006 | 33 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2006 | 20 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2007 | 331 | 0.020 |
Why?
|
| Cadaverine | 1 | 2006 | 4 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 122 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 809 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 1000 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2011 | 538 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2008 | 582 | 0.010 |
Why?
|
| Keratin-12 | 1 | 2005 | 3 | 0.010 |
Why?
|
| Keratins | 1 | 2005 | 49 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 1218 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 1400 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2008 | 897 | 0.010 |
Why?
|
| Loteprednol Etabonate | 1 | 2004 | 5 | 0.010 |
Why?
|
| Suspensions | 1 | 2004 | 8 | 0.010 |
Why?
|
| Tonometry, Ocular | 1 | 2004 | 27 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 960 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 665 | 0.010 |
Why?
|
| Nestin | 1 | 2004 | 15 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2004 | 12 | 0.010 |
Why?
|
| Genes, erbB-1 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 649 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 600 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 23 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 214 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 131 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2008 | 715 | 0.010 |
Why?
|
| Integrins | 1 | 2004 | 90 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 559 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1239 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2004 | 290 | 0.010 |
Why?
|
| Cadherins | 1 | 2004 | 184 | 0.010 |
Why?
|
| Swine | 1 | 2006 | 1184 | 0.010 |
Why?
|
| Lung | 1 | 2010 | 1533 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 1620 | 0.010 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2000 | 11 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2006 | 14939 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1081 | 0.010 |
Why?
|
| Child | 2 | 2006 | 26086 | 0.010 |
Why?
|